There has been an explosion of interest in THCV recently, as well as a number of other uncommon cannabinoids. There will be big winners and losers in rare cannabinoid markets, but at the end of the day, the highest quality and lowest cost producers will capture most of these markets.
In this article, Aaron Green sits down with Bruce Macdonald, Chairman of C21 Investments, Inc. to learn more about the how he got involved with the MSO, the company’s strategy and how C21 delivers competitive advantage in today’s market.
The post Q&A with Bruce Macdonald, Chairman of C21 Investments appeared first on Cannabis Industry Journal.
Prospects for the New Year are expected to continue the explosive year-end trend with a backlog of nearly $2 billion in deals heading into 2021. Growth is expected to be led by multi-state operators who have achieved scale, cleaned up their balance sheets and stockpiled dry powder for roll-up acquisitions.